[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100649829":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":25,"centralContacts":30,"locations":24,"responsibleParty":36,"collaborators":24,"id":38,"slug":39,"hasResults":40,"nctId":41,"briefTitle":42,"officialTitle":43,"acronym":24,"eligibilityCriteria":44,"healthyVolunteers":40,"sex":45,"minAge":46,"maxAge":47,"enrollmentInfo":48,"targetDuration":24,"studyType":51,"phases":52,"briefSummary":54,"conditions":55,"keywords":58,"overallStatus":63,"whyStopped":24,"lastUpdateSubmitDate":64,"lastUpdatePostDateStruct":65,"startDateStruct":68,"completionDateStruct":70,"leadSponsor":72,"locationsCount":24},{"fullName":5,"class":6},"Bursa Yuksek Ihtisas Training and Research Hospital","OTHER_GOV",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"S-FIB","ACTIVE_COMPARATOR","Active ultrasound-guided Suprainguinal Fascia Iliaca Block",[13],"Drug: PCA",{"label":15,"type":10,"description":16,"interventionNames":17},"ACB","Active ultrasound-guided Adductor Canal Block",[13],[19],{"type":20,"name":21,"description":22,"armGroupLabels":23,"otherNames":24},"DRUG","PCA","All patients receive standardized spinal anesthesia and postoperative intravenous PCA tramadol within a standardized multimodal regimen.",[15,9],null,[26],{"name":27,"affiliation":28,"role":29},"Korgün Ökmen, PhD.MD","University of Health Sciences, Bursa Yuksek Ihtisas Training and Research Hospital, Department of Anesthesiology and Reanimation","PRINCIPAL_INVESTIGATOR",[31],{"name":32,"role":33,"phone":34,"phoneExt":24,"email":35},"Korgün Ökmen","CONTACT","+905057081021","korgunokmen@gmail.com",{"type":29,"investigatorFullName":32,"investigatorTitle":37,"investigatorAffiliation":5,"oldNameTitle":24,"oldOrganization":24},"Principal Investigator.PhD.MD","100649829","suprainguinal-fascia-iliaca-block-vs-adductor-canal-block-for-analgesia-after-total-knee-arthroplasty-100649829",false,"NCT07739108","Suprainguinal Fascia Iliaca Block vs. Adductor Canal Block for Analgesia After Total Knee Arthroplasty","Comparing Suprainguinal Fascia Iliaca Block Versus Adductor Canal Block for Postoperative Pain Control Following Total Knee Arthroplasty;A Prospective, Double-Blind Controlled Trial","Inclusion Criteria:\n\n* ASA Physical Status I, II, or III\n* Scheduled for elective unilateral primary total knee arthroplasty\n* Able to understand and operate the PCA device\n* Written informed consent provided\n\nExclusion Criteria:\n\n* Pre-existing lower-extremity neurological deficit or motor weakness (e.g., severe diabetic neuropathy)\n* Chronic opioid use (\\>30 mg oral morphine equivalents\u002Fday for \\>3 months)\n* Infection at the block site or systemic sepsis\n* Coagulopathy or bleeding diathesis\n* Allergy to local anesthetics or study medications\n* Revision TKA or bilateral knee procedures\n* Cognitive impairment or inability to perform mobility\u002Fpain assessments","ALL","45 Years","100 Years",{"count":49,"type":50},60,"ESTIMATED","INTERVENTIONAL",[53],"NA","This study evaluates the analgesic efficacy and motor-sparing properties of ultrasound-guided Suprainguinal Fascia Iliaca Block (S-FIB) compared with Adductor Canal Block (ACB) in patients undergoing primary total knee arthroplasty (TKA). The main hypothesis is that ACB better preserves quadriceps muscle strength, allowing earlier functional mobilization, while providing comparable (non-inferior) analgesia to S-FIB.",[56,57],"Arthroplasty","Knee Osteoarthritis",[59,60,61,62],"Suprainguinal Fascia Iliaca Block","Adductor Canal Block","Ultrasound-Guided Nerve Block","Regional Anesthesia","NOT_YET_RECRUITING","2026-07-31",{"date":66,"type":67},"2026-08-03","ACTUAL",{"date":69,"type":50},"2026-08-12",{"date":71,"type":50},"2027-09-12",{"name":5,"class":6}]